Acrivon Therapeutics Inc.... (ACRV)

5.25

-0.06 (-1.13%)

At close: Mar 03, 2025, 12:25 PM

Acrivon Therapeutics Common Stock Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	-60.39M	-31.17M	-16.24M	-5.31M
Depreciation & Amortization	536K	364K	37K	13K
Stock-Based Compensation	11.62M	2.19M	497K	3K
Other Working Capital	4.53M	-1.29M	-470K	236K
Other Non-Cash Items	1.06M	33K	1.14M	2.1M
Deferred Income Tax	-3.61M	n/a	255K	71K
Change in Working Capital	8.14M	-1.53M	328K	317K
Operating Cash Flow	-42.64M	-30.12M	-13.98M	-2.8M
Capital Expenditures	-1.29M	-2.17M	-238K	-15K
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-56.53M	-150.18M	n/a	n/a
Sales Maturities Of Investments	108.53M	10.67M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	50.72M	-141.68M	-238K	-15K
Debt Repayment	n/a	n/a	n/a	58K
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.55M	-2.75M	112.22M	2.83M
Financial Cash Flow	-1.55M	101.71M	112.22M	2.89M
Net Cash Flow	6.52M	-70.08M	98M	71K
Free Cash Flow	-43.93M	-32.28M	-14.22M	-2.82M